Xeris Biopharma Holdings, Inc. (XERS)
6.93
-0.08
(-1.14%)
USD |
NASDAQ |
Dec 10, 10:57
Xeris Biopharma Holdings Market Cap: 1.150B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 91.24M |
| Assertio Holdings, Inc. | 75.09M |
| Amneal Pharmaceuticals, Inc. | 3.766B |
| NovaBay Pharmaceuticals, Inc. | 267.14M |
| Palatin Technologies, Inc. | 25.98M |
Market Cap Related Metrics
| PS Ratio | 4.157 |
| Price to Free Cash Flow | 110.92 |
| Price | 6.93 |
| Earnings Yield | -1.49% |
| Operating PE Ratio | 112.88 |